Novartis India Ltd (NOVARTIND) — FY26 Annual Report | 9 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
78th AGM scheduled for September 24, 2026 via video conference.
🔄 What Changed
AGM date and format announced; compliance reminders added for KYC and electronic payments.
🔮 What's Next
AGM to be conducted via video conference; shareholders urged to update KYC and email for continued communications.
💡 Investor Takeaway
Shareholders must update KYC details and email to receive future communications and payments electronically.

Novartis India announced that its 78th Annual General Meeting will be held on September 24, 2026 via video conference, and dispatched physical letters to shareholders without registered emails containing the Annual Report 2025-26 link and compliance reminders for KYC updates and electronic payments.

📄 View Original Announcement (PDF)

About Novartis India Ltd (NOVARTIND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹5,908.88 Cr P/E: 60.4 ROE: 11.9% ROCE: 16.7%

View full NOVARTIND stock details →

📡 Get AI alerts when NOVARTIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NOVARTIND — Free

📊 More NOVARTIND filings

See all NOVARTIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NOVARTIND files new disclosures

Track NOVARTIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NOVARTIND — Free

Free account · 2 AI queries/day